A noticeable shift in medical thinking is influencing how longevity care and hormone therapy are practiced today. Greater attention now centers on timely intervention, measurable health performance, and sustained physiological readiness.
Within this context, Dr. Lorna A. Brudie, Medical Director at Excel Medical, represents a decisive commitment to prevention shaped by years in surgical oncology. She has managed advanced disease cases that demanded precision and timely judgment. These experiences formed her belief that structured hormone optimization can support long-term patient outcomes.
Dr. Brudie leads one of the nation’s most innovative functional and longevity practices at Excel Medical, setting the clinical standards for advanced hormonal, metabolic, and preventive care for both women and men. Widely recognized as a national leader in female hormone optimization, she has helped redefine how women’s hormonal health is understood, treated, and optimized across all stages of life.
Excel Medical, through its Fem Excel and Male Excel brands, is a national telehealth medical practice focused on hormone optimization, longevity and preventive care, having served over 100,000 patients since 2019.
Dr. Brudie applies disciplined clinical thinking to patient-centered protocols that prioritize vitality, functional capacity, and quality of life. She promotes preventive strategies grounded in medical evidence and consistent performance tracking. Through her leadership, contemporary healthcare recognizes prevention as a practical priority that aligns clinical authority with forward-looking health expectations. Dr. Brudie is also recognized as The Most Influential Woman Femtech Leader to Watch in 2026, and she continues to shape the future of preventive and hormone-based healthcare.
Clinical foundations: Dual board certified authority
Dr. Brudie’s professional identity reflects her distinction as a dual board-certified gynecologic oncologist and obstetrician-gynecologist. This qualification represents disciplined training, sustained performance standards, and a deep commitment to women’s health. Her early clinical years unfolded in surgical oncology environments where she handled complex disease presentations that required decisive judgment and technical accuracy. These responsibilities shaped a precision-based approach that continues to guide her patient care philosophy.
Across decades of practice, Dr. Brudie built a strong understanding of hormonal physiology and its influence on long-term health outcomes. She supervised demanding treatment pathways that called for structured monitoring, patient education, and confident clinical leadership. Her journey includes surgical team coordination, management of high-risk cases, and engagement with challenging therapeutic decisions. Each stage strengthened her methodical approach to assessment and intervention.
Today, Dr. Brudie applies this clinical discipline to hormone optimization medicine, ensuring preventive strategies remain purposeful, evidence-guided, and aligned with measurable patient well-being.
Preventive endocrine authority
Dr. Lorna A. Brudie is recognized as a leading physician in hormone replacement therapy optimization, known for her clarity in clinical communication and responsible advocacy. Her participation in professional forums reflects a sustained commitment to advancing the understanding of endocrine science. She explains complex hormonal mechanisms with structured precision, enabling practitioners and patients to make informed health decisions grounded in medical reasoning.
As a speaker and educator, Lorna contributes to initiatives that expand awareness of hormonal health across different life stages. She engages in discussions on aging, metabolic stability, and performance longevity, presenting insights shaped by clinical experience. Her involvement in practitioner education programs encourages careful assessment, personalized treatment planning, and consistent evaluation of patient outcomes.
Dr. Brudie also leads patient awareness conversations that focus on realistic expectations and long-term well-being. Through evidence-guided perspectives and transparent dialogue, she builds confidence in hormone therapy optimization practices. Her leadership continues to influence professional understanding while reinforcing trust in preventive hormonal care.
Influence Highlights:
- Recognized speaker in hormone optimization forums
- Contributor to practitioner education initiatives
- Advocate for metabolic and longevity health awareness
- Promoter of transparent, evidence-based hormone therapy guidance to patients and clinicians to address gaps in clinical education
She continues to advance preventive hormone care through credible clinical leadership that strengthens professional confidence and patient trust.
Hormonal science across life stages
Dr. Brudie’s work in women’s hormonal health reflects decades of focused clinical engagement across different physiological stages.
- Reproductive Transitions: She guides patients through hormonal fluctuations linked with reproductive phase changes. Her approach prioritizes structured evaluation and timely intervention to maintain functional stability and overall well-being.
- Menopause and Perimenopause Strategy: Lorna addresses menopause and perimenopause with evidence-guided therapy planning that supports symptom management and long-term health performance. She emphasises strength preservation, bone health awareness, and cardiovascular considerations within treatment discussions.
- Metabolic Risk Awareness: Her clinical assessments highlight the connection between hormonal balance and metabolic indicators. She encourages early monitoring and personalized strategies that support sustained physical capacity.
- Vitality and Cognitive Stability: Lorna links hormonal optimization with mental clarity, energy regulation, and resilience in daily activity. She integrates diagnostic insights with tailored therapeutic pathways that align with individual health goals.
Her clinical commitment continues to help women sustain long-term health performance, functional independence, and everyday vitality through informed hormonal care.
Functional oncology perspective
Clinical experience in oncology continues to influence Dr. Lorna A. Brudie’s preventive thinking with clarity and purpose. Her experience with complex disease progression shaped a strong focus on recognizing risk patterns at an earlier stage.
1. What oncology taught her
Years of clinical responsibility in oncology exposed Lorna to the consequences of delayed risk recognition and complex disease progression. Managing demanding treatment pathways strengthened her sensitivity to sustained physiological imbalance and its influence on chronic health vulnerability. This experience shaped a disciplined analytical mindset focused on early evaluation and structured monitoring.
2. How she applies it today
Dr. Brudie translates oncology insight into proactive hormonal monitoring and metabolic vigilance within preventive care. She studies biological patterns that may indicate reduced functional resilience and increased long-term risk. By combining established clinical reasoning with deeper evaluation of contributing influences, she supports timely therapeutic planning grounded in scientific accountability. Her approach prioritizes consistent diagnostic review and personalized intervention strategies that sustain measurable health performance.
3. Why prevention matters
This clinical perspective defines Dr. Lorna A. Brudie’s leadership philosophy. She positions prevention as a responsible medical priority that protects functional capacity and supports evidence-guided long-term health planning.
This functional oncology lens continues to guide Dr. Brudie’s clinical leadership, reinforcing her commitment to responsible prevention and sustained patient health outcomes.
Inside her role at Excel medical
At Excel Medical/Fem Excel/Male Excel, Dr. Brudie oversees clinical operations in telehealth hormone optimization and preventive care services, providing strategic guidance to ensure consistent, patient-centered outcomes.
Her responsibilities include establishing treatment protocols that support consistent therapeutic standards across physician teams. She evaluates clinical processes to ensure patient safety, clarity in communication, and measurable health outcomes within remote care environments. Dr. Brudie and Excel Medical Chief Medical Officer Dr. Peter Fotinos personally provide detailed training sessions with the in-house provider network of doctors, nurse practitioners, and healthcare professionals that provide critical support to tens of thousands of patients. The doctors host semi-annual in-person training sessions. Each member of the Excel Medical provider network gets a minimum of 100 hours of training per year to keep up on the latest evidence-based advances.
In supervising these multidisciplinary practitioners, Dr. Brudie encourages structured assessment methods and personalized treatment planning aligned with evidence-guided practice. Her leadership supports coordinated decision-making that maintains treatment consistency while addressing individual physiological needs and treating symptoms. She also contributes to patient education strategies that help individuals understand therapy goals, monitoring requirements, and long-term health expectations.
Excel Medical operates as a nationwide telemedicine company specializing in hormone optimization services, with dedicated divisions, Fem Excel and Male Excel. These focused care pathways address gender-specific hormonal considerations through targeted clinical frameworks. Lorna contributes medical oversight within these operational models, supporting innovation adoption and performance evaluation.
Her role continues to uphold high standards of personalized care while enabling scalable delivery systems that prioritize precision, accountability, and sustained patient well-being.
Milestones of clinical influence
Professional milestones in Dr. Lorna A. Brudie’s journey reflect consistent clinical credibility and visible contributions to preventive health dialogue. Each recognition highlights her commitment to responsible hormone therapy awareness and patient-centered medical advocacy.
Spotlight 1: Speaking visibility, thought leadership in HRT, TRT, BHRT
Dr. Brudie has gained professional visibility through invitations to address national and international clinical forums focused on hormone optimization and preventive health. These engagements reflected trust in her ability to communicate endocrine science with clarity and responsible clinical judgement, and represent her reputation as a leading innovator in the HRT/TRT/BHRT space and thought leader. Among other industry presentations, Dr. Brudie spoke at the SIO Europe/12th International ARTOI Congress in Rome in May, on
Integrating Longevity Medicine into Women’s Cancer Survivorship: A Proactive Framework to Improve Resilience, Hormonal Recovery, Long-Term Outcomes. She is also scheduled to present at other major industry conferences later this year.
Spotlight 2: Clinical education contribution
Her participation in practitioner education initiatives supported the advancement of safe and personalized hormone therapy practices. Dr. Lorna A. Brudie shared structured insights on diagnostic evaluation, treatment monitoring, and patient communication that strengthened clinical understanding across diverse healthcare settings.
Spotlight 3: Professional credibility recognition
Engagement in expert panels and industry discussions has positioned Dr. Lorna A. Brudie as an industry leader and credible voice in conversations related to aging awareness, metabolic health, and long-term functional performance. Her leadership presence demonstrated disciplined medical reasoning and ethical therapeutic planning. Dr. Brudie has recently been featured in Authority Magazine/Medium.com, on The Roxanne Show Podcast, and named a Doctor of the Year, 2026 in Orlando Style Magazine.
Spotlight 4: Preventive health influence
Through patient-centered dialogue and evidence-guided perspectives, Dr. Lorna A. Brudie continues to expand awareness about responsible hormonal care that can have profound benefits to patients. These milestones reinforce her standing as a respected physician within preventive health conversations.
Together, these contributions highlight her ongoing role in advancing preventive hormone care and clinical education.
Preventive priorities for longevity care
Dr. Lorna A. Brudie defines a clear approach to longevity care, grounded in evidence-based science, clinical discipline, and long-term patient outcomes. She believes healthcare systems must prioritize early risk recognition and structured intervention to support sustained physiological stability. Her perspective highlights the importance of embedding preventive thinking within everyday clinical decision-making to reduce future disease burden and preserve functional capacity. Lorna also recognizes the growing relevance of digital care environments in supporting continuity and accessibility of hormonal health services.
Key Future Priorities:
- Central role of preventive strategies in routine medical practice
- Technology-enabled care delivery for wider patient reach
- Data-informed monitoring to support timely therapeutic planning
- Expansion of hormone optimization education initiatives
- Advancing a shift from reactive disease management to proactive, preventive care
- Focus on sustaining vitality and functional independence
Through this vision, Dr. Brudie aims to support informed patient participation and measurable health progress across aging populations. Her outlook reflects a commitment to structured longevity care that promotes confidence, resilience, and long-term performance stability.
Key takeaways:
- Oncology experience shaped a preventive clinical outlook focused on early risk recognition and structured hormonal intervention that benefits patients.
- Dual board certification (gynecologic oncology and OB-GYN) reflects disciplined medical expertise in women’s health and complex disease pathways.
- Evidence-guided hormone optimization supports measurable vitality and sustained functional performance in patient care.
- Clinical direction at Excel Medical ensures treatment consistency and personalized protocols within telehealth systems.
- Professional education engagement expands awareness around responsible, evidence-based hormonal health decision-making.
- A forward-focused vision positions preventive longevity medicine as a practical priority in contemporary healthcare.
| An Open Letter to the Next Generation of Physicians To the patients I’ve cared for, the clinicians doing this work beside me, and those just stepping into medicine— My perspective comes from years in surgical oncology, paired with a deep focus on hormone optimization and prevention. I’ve seen what happens when we recognize risk too late. By the time many patients reach us, the trajectory is already set—often in ways that could have been altered much earlier. That reality is what pushed me to think differently about care. We cannot keep waiting for disease to declare itself before we act. Hormone health, metabolic function, and early physiologic changes deserve attention long before pathology develops. Prevention should not be an afterthought—it should be built into how we practice, how we think, and how we guide our patients. We now have the tools to do this better. Technology allows us to follow patients more closely, track meaningful data over time, and make decisions with greater precision. But tools alone are not enough. Clinical judgment—grounded in experience and responsibility—still matters. So does education. Patients deserve to understand what we’re doing, why it matters, and how to actively participate in their own care—whether we’re talking about hormones, metabolism, or long-term disease prevention. At Excel Medical, my focus remains on delivering individualized care in a way that is both scalable and accountable. Telehealth has expanded what’s possible, but the standard of care cannot be diluted in the process. Longevity medicine, when done correctly, is not about chasing trends. It’s about preserving function, maintaining independence, and supporting patients in a way that allows them to stay strong, capable, and informed as they age. This is where medicine is going. The question is whether we’re willing to evolve with it. Warm regards, Dr. Lorna A. Brudie Medical Director, Excel Medical |
